Bristol-Myers Squibb Company

Release Summary

Bristol-Myers Squibb and Apexigen, Inc. Announce Clinical Collaboration to Evaluate Opdivo (nivolumab) in Combination with APX005M in Advanced Solid Tumors

Bristol-Myers Squibb Company